TickerFacts.

GT Biopharma, Inc. (GTBP): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2017-12-31
$226.0K2010-12-31: $65.0K2011-12-31: $48.0K2012-12-31: $94.0K2013-12-31: $226.0K2014-12-31: $57.0K2015-12-31: $02016-12-31: $02017-12-31: $0$0
2010-12-31 Cost of Revenue (USD) 2017-12-31
Period endedCost of RevenueChange YoYSource filing
2017-12-31$0n/a2018-03-01, From 2017-01-01
2016-12-31$0n/a2018-03-01, From 2016-01-01
2015-12-31$0-100.0%2018-02-28, From 2015-01-01
2014-12-31$57.0K-74.8%2018-02-28, From 2014-01-01
2013-12-31$226.0K+140.4%2015-03-31, From 2013-01-01
2012-12-31$94.0K+95.8%2015-01-08, From 2012-01-01
2011-12-31$48.0K-26.2%2014-11-18, From 2011-01-01
2010-12-31$65.0Kn/a2012-04-16, From 2010-01-01